Suggestions
Frank Cesaro
VP of Sales and CS at SiteRx
Frank Cesaro is an experienced sales and customer success leader currently serving as the VP of Sales and Customer Success at SiteRx, a company focused on improving the clinical trial process.12 Here's an overview of his professional background:
Career Highlights
Frank has spent over a decade in leadership roles, building teams for fast-growing companies in the digital health sector.1 His career progression includes:
Current Role:
- VP of Sales and Customer Success at SiteRx (September 2023 - Present)1
Previous Positions:
- VP of Sales at SiteRx (March 2022 - September 2023)1
- VP of Sales at Castor (February 2019 - March 2022)1
- Various roles at Zocdoc, including Head of Sales (Outbound) and Regional Sales Manager (2013 - 2019)1
Education and Expertise
Frank holds a Bachelor of Science degree in Kinesiology and Exercise Science from Rutgers University.2 His expertise lies in:
- Building and leading sales teams
- Driving revenue growth
- Managing full sales cycles
- Developing customer success strategies
Additional Involvement
Frank has also contributed to the academic sector, serving as an Advisory Board Member for the Rutgers University Division of Continuing Studies from January 2019 to June 2020.1 In this role, he helped develop programs focused on disruptive innovation and emerging technologies.2
At SiteRx, Frank leads the Sales and Customer Success team, which is responsible for connecting doctors and patients with suitable clinical trials and ensuring client satisfaction throughout the process.3
Highlights
Last week I started a new role at SiteRx, as VP of Sales. I’ve spent the past decade leading teams for digital health startups centered around empowering patients to have better access to quality healthcare and clinical trials.
You soon begin to realize that these processes struggle to work together and in return patients are missing out on potential life saving or altering treatment options due to lack of awareness and broken systems.
We equip doctors to incorporate clinical research as a patient care option. Could not be more excited to take on this challenge and create better healthcare outcomes for the masses!
I want to thank my previous employer Castor and Derk Arts, MD PhD for a memorable experience and tons of growth we created over the past three years. I’ll be rooting from behind the scenes as you continue to democratize clinical research.
Castor has raised a $45M Series B and received a feature in TechCrunch!
This is easily the proudest moment of my career and tough to sum up. Not too long ago we were a tiny startup, with the dream of making an impact on patient centered clinical research globally. We are now making it happen.
So many people to thank, but wanted to shout out all of the team members in sales both past and present, who contributed to our growth. Without you all, we would not be where we are today.
Thanks to Eight Roads and F-Prime Capital leading the round, with backing from our existing investors Two Sigma Ventures INKEF Capital
#clinicaltrials #seriesb #innovation #decentralizedtrials #hiring
